Merck & Co., Inc. Kenilworth, N.J., U.S.A. known as Merck in the United States and Canada, is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. Today, we are building a new kind of healthcare company – one that is ready to help create a healthier future for all of us.
Our ability to excel depends on the integrity, knowledge, imagination, skill, diversity and teamwork of an individual like you. To this end, we strive to create an environment of mutual respect, encouragement and teamwork. As part of our global team, you’ll have the opportunity to collaborate with talented and dedicated colleagues while developing and expanding your career.
The MRL Ventures Fund is the Cambridge, MA- based corporate venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures Fund creates and/or invests in seed and early-stage therapeutics companies, based on translatable breakthrough science, with the potential to deliver highly differentiated new medicines to improve human health.
This is a rare opportunity for an experienced, proven life-science venture professional to join as a senior investment professional at the start-up stage of a nimble, early-stage venture capital fund.
The Partner MRL Ventures Fund, will be responsible for the full-range of venture investing activities from deal sourcing and diligence, through syndication and negotiation, through post-close deal management and board representation.
The Partner will also be expected to be able to lead all aspects of new company creation, as part of the fund’s venture creation efforts and to play a leadership role in fund operational and strategic activities as requested by the fund President.
